Haleon: Tailwinds Are Mostly Priced In
Despite strong cash flow and organic growth in most of its key brands, high leverage and mixed valuation ratios lead to a ...
Future Market Insights56m
Allergy Treatment Market Projected to Reach USD 38.9 Billion by 2032 at a 6.9% of CAGR, Fueled by Growing Prevalence and Innovative Therapies
The allergy treatment market is set to experience robust growth, with an estimated valuation of US$ 20.20 billion in 2022 and ...
FiercePharma20m
GSK embarks on Pennsylvania manufacturing expansion worth up to $800M, creating 200 new jobs
After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
On Thursday, GSK plc (NYSE:GSK) revealed new preliminary data for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) in ...
Central Penn Business Journal25m
Global biopharma company expanding Lancaster facility, investing $800M in Pa.
Global biopharma company GSK is investing up to $800 million in Pennsylvania and expanding its facility in Lancaster County.